Amos Grünebaum: The Cost of Ideology in Fertility Treatments
Amos Grünebaum, Professor of Obstetrics and Gynecology Donald and Barbara Zucker School of Medicine, shared at on LinkedIn:
“IVF, ‘Natural’ Medicine, and the Cost of Ideology
When fertility care is framed as a moral project rather than a medical one, patients pay the price. A new JAMA Viewpoint examines how so-called ‘restorative reproductive medicine’ restricts access to IVF and other evidence-based treatments, not because they are unsafe, but because they conflict with ideology. In this piece, I unpack why denying effective care in the name of ‘natural’ medicine is neither ethical nor patient-centered, and why this debate matters far beyond infertility clinics.
More here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 1, 2026, 03:13International Expert Recommendations in Emerging Reproductive Science – ESHRE
-
Apr 30, 2026, 18:45AI in Ultrasound Follicular Monitoring Moves Toward Clinical Decision Support – RBMO
-
Apr 30, 2026, 11:42ASRM Encourages Registration for Conference on Practice Growth and Innovation
-
Apr 30, 2026, 11:26ESHRE and ALPHA Launch Global Survey to Update ART Laboratory KPIs
-
Apr 30, 2026, 11:10Susanne Johnson: Advanced Gynaecology Ultrasound Course Day 2
-
Apr 30, 2026, 11:02Platelets Reduce Oxidative Stress Damage in Human Endometrial Stromal Cells in Vitro – RBMO
-
Apr 30, 2026, 10:57GREEG Day 2026: Elevate Your Ultrasound Expertise – GREEG
-
Apr 30, 2026, 10:49Up to Two-Thirds of Elite Female Athletes Experience Irregular Periods – Fertility Plus
-
Apr 30, 2026, 10:47Applications for the ESHRE5 Young Ambassadors 2026 are Still OPEN, But Not for Long! – ESHRE